Coherus Oncology Ownership | Who Owns Coherus Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Coherus Oncology Ownership Summary


Coherus Oncology is owned by 32.21% institutional investors, 15.01% insiders, and 52.79% retail investors. Blackrock is the largest institutional shareholder, holding 10.42% of CHRS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.96% of its assets in Coherus Oncology shares.

CHRS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCoherus Oncology32.21%15.01%52.79%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock11.75M10.42%$20.33M
Blackrock funding, inc. /de10.56M9.09%$15.00M
Vanguard group10.03M8.63%$14.24M
Tang capital management5.10M4.39%$8.36M
Kohlberg kravis roberts3.04M2.62%$4.93M
Geode capital management2.75M2.36%$3.90M
State street2.22M1.92%$3.65M
Cm management2.10M1.81%$2.98M
C worldwide group1.93M1.66%$2.74M
Panagora asset management1.62M1.39%$2.30M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cm management2.10M2.51%$2.98M
Tang capital management5.10M0.32%$8.36M
Kohlberg kravis roberts3.04M0.08%$4.93M
Gsa capital partners llp477.48K0.06%$678.00K
Tyche wealth partners220.87K0.05%$313.63K
C worldwide group1.93M0.05%$2.74M
State of wyoming119.27K0.02%$164.59K
Wealth group14.20K0.02%$20.00K
Providence wealth advisors15.00K0.01%$21.68K
Carr financial group35.20K0.01%$49.98K

Top Buyers

HolderShares% AssetsChange
Jacobs levy equity management1.00M0.01%1.00M
Blackrock11.75M0.00%521.98K
Norges bank491.50K0.00%491.50K
Gsa capital partners llp477.48K0.06%477.48K
Jane street group603.51K0.00%393.53K

Top Sellers

HolderShares% AssetsChange
Temasek (private)---5.82M
Point72 asset management---5.28M
Bank of america corp /de/275.10K--2.15M
Macquarie group---900.00K
Lazard asset management---883.73K

New Positions

HolderShares% AssetsChangeValue
Norges bank491.50K0.00%491.50K$850.29K
Gsa capital partners llp477.48K0.06%477.48K$678.00K
Sei investments76.63K0.00%76.63K$108.81K
Two sigma investments, lp35.71K0.00%35.71K$58.57K
Kestra private wealth services20.00K0.00%20.00K$28.40K

Sold Out

HolderChange
Eagle bay advisors-30.00
Nelson, van denburg & campbell wealth management group-31.00
Cornerstone planning group-49.00
Larson financial group-79.00
Newbridge financial services group-79.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202578-34.45%37,433,194-27.54%321.63%37-32.73%19-42.42%
Sep 30, 202558-48.67%31,871,888-42.43%271.21%22-51.11%21-41.67%
Jun 30, 2025113-4.24%55,361,532-10.83%471.66%46-6.12%35-
Mar 31, 2025117-7.14%61,758,313-5.38%531.66%50-18.03%346.25%
Dec 31, 202475-42.75%35,423,873-53.96%300.69%37-35.09%18-47.06%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.43M2.96%-
Vanguard Total Stock Mkt Idx Inv3.63M2.43%-
iShares Russell 2000 ETF2.59M1.73%990.61K
C WorldWide Healthcare Select 1A1.93M1.29%-
Vanguard Strategic Equity Inv1.58M1.06%-
Vanguard Explorer Inv1.57M1.05%-
AlphaCentric LifeSci Healthcare I1.00M0.87%-
Vanguard Institutional Extnd Mkt Idx Tr1.27M0.85%-
Delaware Healthcare I900.00K0.78%-
Macquarie Healthcare I900.00K0.77%-

Recent Insider Transactions


DateNameRoleActivityValue
May 23, 2025Wahlstrom Mats-Sell$73.88K
Nov 22, 2023Lanfear Dennis M President & CEOSell$449.77K
Oct 15, 2021Stilwell McDavid Chief Financial OfficerSell$58.92K
Sep 28, 2021HEALY JAMES-Sell$829.81K
Sep 27, 2021HEALY JAMES-Sell$1.81M

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2-1
2025 Q1--
2024 Q4--
2024 Q3--

CHRS Ownership FAQ


Who Owns Coherus Oncology?

Coherus Oncology shareholders are primarily institutional investors at 32.21%, followed by 15.01% insiders and 52.78% retail investors. The average institutional ownership in Coherus Oncology's industry, Biotech Stocks , is 382.13%, which Coherus Oncology falls below.

Who owns the most shares of Coherus Oncology?

Coherus Oncology’s largest shareholders are Blackrock (11.75M shares, 10.42%), Blackrock funding, inc. /de (10.56M shares, 9.09%), and Vanguard group (10.03M shares, 8.63%). Together, they hold 28.14% of Coherus Oncology’s total shares outstanding.

Does Blackrock own Coherus Oncology?

Yes, BlackRock owns 10.42% of Coherus Oncology, totaling 11.75M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 20.33M$. In the last quarter, BlackRock increased its holdings by 521.98K shares, a 4.65% change.

Who is Coherus Oncology’s biggest shareholder by percentage of total assets invested?

Cm management is Coherus Oncology’s biggest shareholder by percentage of total assets invested, with 2.51% of its assets in 2.1M Coherus Oncology shares, valued at 2.98M$.

Who is the top mutual fund holder of Coherus Oncology shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Coherus Oncology shares, with 2.96% of its total shares outstanding invested in 3.43M Coherus Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools